Publications Database

Aman M. G. et al. (2005)

Acute and long-term safety and tolerability of risperidone in children with autism.

Journal of Child and Adolescent Psychopharmacology

15(6), pp. 869-884

Read Abstract (New Window)

Campbell M. et al. (1978)

A comparison of haloperidol and behavior therapy and their interaction in autistic children.

Journal of the American Academy of Child and Adolescent Psychiatry

17(4), pp. 640-655

Read Abstract (New Window)

Campbell M. et al. (1989)

Naltrexone in autistic children: an acute open dose range tolerance trial.

Journal of the American Academy of Child and Adolescent Psychiatry

28(2), pp. 200-206

Read Abstract (New Window)

Canitano R. , Scandurra V. (2008)

Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents.

Neuropsychiatric Disease and Treatment

4(4), pp. 723-730

Read Abstract (New Window) Read Full (New Window)

Chavez B. et al. (2007)

Atypical antipsychotics in children with pervasive developmental disorders.

Pediatric Drugs

9(4), pp. 249-266

Read Abstract (New Window)

Cohen D. et al. (2013)

Risperidone or aripiprazole in children and adolescents with autism and/or intellectual disability: A Bayesian meta-analysis of efficacy and secondary effects.

Research in Autism Spectrum Disorders

7(1), pp. 167-175.

Read Abstract (New Window)

Coskun M. et al. (2009)

Effectiveness of mirtazapine in the treatment of inappropriate sexual behaviors in individuals with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

19(2), pp. :203-206

Read Abstract (New Window)

Curran L. K. et al. (2007)

Behaviors associated with fever in children with autism spectrum disorders.

Behavioural Brain Research

(120), e1386-1392

Read Abstract (New Window)

Findling R. L. , Maxwell K. , Wiznitzer M. (1997)

An open clinical trial of risperidone monotherapy in young children with autistic disorder.

Psychopharmacology Bulletin

33(1), pp. 155-159

Read Abstract (New Window)

Handen B. L. , Sahl R. , Hardan A. Y. (2008)

Guanfacine in children with autism and/or intellectual disabilities.

Journal of Developmental and Behavioral Pediatrics

29(4), pp. 303-308

Read Abstract (New Window)

Hardan A. Y. , Jou R. , Handen B. L. (2005)

Retrospective study of quetiapine in children and adolescents with pervasive developmental disorders

Journal of Autism and Developmental Disorders

35 pp. 387-391

Read Abstract (New Window)

King B. et al. (2003)

Use of risperidone in a paediatric population: an observational study.

Journal of Paediatrics and Child Health

39(7), pp. 523-527

Read Abstract (New Window)

Kirino E. (2014)

Efficacy and tolerability of pharmacotherapy options for the treatment of irritability in autistic children.

Clinical Medicine Insights: Pediatrics

May, 8 pp. 17-30.

Read Abstract (New Window) Read Full (New Window)

Lemmon M. E. , Gregas M. , Jeste S. S. (2011)

Risperidone use in autism spectrum disorders: A retrospective review of a clinic-referred patient population.

Journal of Child Neurology

26(4), pp. 428-432

Read Abstract (New Window)

Malone R. P. et al. (2001)

Olanzapine versus haloperidol in children with autistic disorder: an open pilot study.

Journal of the American Academy of Child and Adolescent Psychiatry

40 pp. 887-894.

Read Abstract (New Window)

Malone R. P. et al. (2002)

Risperidone treatment in children and adolescents with autism: short- and long-term safety and effectiveness.

Journal of the American Academy of Child and Adolescent Psychiatry

41(2), pp. 140-147

Read Abstract (New Window)

Martin A. et al. (1992)

Open-label quetiapine in the treatment of children and adolescents with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

9(2), pp. 99-107

Read Abstract (New Window)

Matson J. L. , Hess J. A. (2011)

Psychotropic drug efficacy and side effects for persons with autism spectrum disorders.

Research in Autism Spectrum Disorders

51

Read Abstract (New Window)

McCracken J. T. et al. (2002)

Risperidone in children with autism and serious behavioral problems.

New England Journal of Medicine

347(5), pp. 314-321

Read Abstract (New Window) Read Full (New Window)

McDougle C. J. et al. (1998)

A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.

Archives of General Psychiatry

55(7), pp. 633-641

Read Abstract (New Window) Read Full (New Window)